Balancing the cardiometabolic benefits and risks of statins

Gerald F Watts; Esther M Ooi

doi:10.1016/S0140-6736(12)61301-4

Balancing the cardiometabolic benefits and risks of statins

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	541-543
Number of pages	3
Journal	The Lancet
Volume	380
Issue number	9841
DOIs	https://doi.org/10.1016/S0140-6736(12)61301-4
Publication status	Published - 11 Aug 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(12)61301-4

Cite this

@article{77c679fd0bb0449a973b4fe744f1791a,

title = "Balancing the cardiometabolic benefits and risks of statins",

keywords = "Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Fluorobenzenes, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Male, Pyrimidines, Rosuvastatin Calcium, Sulfonamides, Comment, Journal Article",

author = "Watts, {Gerald F} and Ooi, {Esther M}",

year = "2012",

month = aug,

day = "11",

doi = "10.1016/S0140-6736(12)61301-4",

language = "English",

volume = "380",

pages = "541--543",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Academic Press",

number = "9841",

}

TY - JOUR

T1 - Balancing the cardiometabolic benefits and risks of statins

AU - Watts, Gerald F

AU - Ooi, Esther M

PY - 2012/8/11

Y1 - 2012/8/11

KW - Cardiovascular Diseases

KW - Diabetes Mellitus, Type 2

KW - Female

KW - Fluorobenzenes

KW - Humans

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors

KW - Male

KW - Pyrimidines

KW - Rosuvastatin Calcium

KW - Sulfonamides

KW - Comment

KW - Journal Article

U2 - 10.1016/S0140-6736(12)61301-4

DO - 10.1016/S0140-6736(12)61301-4

M3 - Comment/debate

C2 - 22883491

SN - 0140-6736

VL - 380

SP - 541

EP - 543

JO - The Lancet

JF - The Lancet

IS - 9841

ER -